CompletedNot Applicable

Three-dimensional (3D) Rectal Water Contrast Transvaginal Ultrasonography Versus Computed Colonography in the Diagnosis of Rectosigmoid Endometriosis

Italy68 participantsStarted 2017-03-01

Plain-language summary

Rectosigmoid involvement by endometriosis causes intestinal symptoms such as constipation, diarrhea, and dyschezia. A non-invasive diagnosis of bowel endometriosis is relevant to provide the patients information on the potential hormonal or surgical treatments. The objective of the current study was to compare the performance of three-dimensional rectal water contrast transvaginal ultrasonography (3D-RWC-TVS) and computed colonography (CTC) in predicting the presence and characteristics of rectosigmoid endometriosis.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- pain and intestinal symptoms suggestive of rectosigmoid endometriosis Exclusion Criteria: * previous surgical diagnosis of intestinal endometriosis * previous radiological diagnosis of intestinal endometriosis (based on Magnetic Resonance or double-contrast barium enema * history of colorectal surgery (except appendectomy) * contraindications to bowel preparation or computed colonography (such as non-- compliant patients and rectal malformations) * previous bilateral ovariectomy * psychiatric disorders

What they're measuring

To compare the accuracy of 3D-RWC-TVS and CTC in the diagnosis of rectosigmoid endometriosis.

Timeframe: At maximum 6 months before laparoscopic surgical approach

Trial details

NCT IDNCT04295343

SponsorOspedale Policlinico San Martino

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-09-01

View on ClinicalTrials.gov More Endometriosis, Sigmoid trials